Proteolytic fragments of fibronectin were used (I ) to identify regions of the molecule that support neurite extension and (2) Fibronectin fragments with differing biological activities were produced by proteolytic digestion with trypsin and cathepsin D and sequential affinity chromatography on gelatinagarose and heparin-Sepharose.
, for review). Neurons also bind in vitro to FN-treated surfaces (Akers et al., 1981; Baron-VanEvercooren et al., 1982; Carbonetto et al., 1983; Rogers et al., 1983) , and definition of this response is important to elucidation of (1) the potential role(s) of FN in axonal growth and (2) variations among cell types in FN-mediated behavior. The behavior of neurons in response to FN appears to vary with culture conditions, developmental stage, and embryonic origin. FN promotes adhesion and directional motility of neural crest cells (Erickson and Turley, 1983; Rovasio et al., 1983) . Peripheral sensory and sympathetic ganglion neurons, derived from neural crest, also adhere to and extend neurites on FN (Carbonetto et al., 1983; Rogers et al., 1983) , as do neuroblastoma cells (Rauvala, 1984) . In contrast, spinal cord neurons do Vol. 5, No. 2, Feb. 1985 not respond to FN bound to tissue culture plastic (Rogers et al., 1983) or when added to conditioned medium (Dribin and Barrett, 1980) . Cerebellar cells adhere to FN substrata in uitro, but only after a specific developmental stage when FN is reported to appear along the path of granule cell migration (Hatten et al., 1982) . Dissociated retinal neurons do not appear to respond to substratum-bound FN (Adler and Hewitt, 1983; Rogers et al., 1983 ; see also Thompson and Pelto, 1982) , although aggregates of retinal cells may extend neurites on this glycoprotein (Akers et al., 1981) . Proteolytic fragments of FN have been used to map biologically active domains within the FN molecule (see Furcht, 1983 , for review). Attachment and spreading of several cell lines, as well as fibroblast chemotaxis, seem to be promoted by a specific region of the molecule (Hahn and Yamada, 1979; Sekiguchi and Hakomori, 1980; Pierschbacher et al., 1981; Ruoslahti et al., 1981; Hayashi and Yamada, 1983) . Recently, sensory neurons have also been reported to interact with a similar segment of FN (Carbonetto et al., 1983) . We used peptide fragments similar to those studied by other investigators and characterized by Smith et al. (1982) and Smith and Furcht (1982) to better define possible mechanisms of neuron-FN interaction.
In an earlier study (Rogers et al., 1983) , we found that peripheral (PNS) but not central nervous system (CNS) neurons extended neurites on intact FN bound to plastic substrata. This behavioral difference between the two types of neuron might be due to differential binding affinity for FN in uitro, absence of CNS cell surface receptors for FN or inability of CNS cells to interact with particular conformations of FN. By testing the responses of these neurons to isolated portions of FN, we have (1) further defined differences between central and peripheral neurons in response to FN and (2) identified two apparently distinct regions of the FN molecule that can mediate and/or modulate cell attachment and neurite outgrowth.
Materials and Methods

Preparation of FN
Fibronectin (FN) was isolated from human plasma on DEAE-cellulose and gelatin affinity columns as previously described (Smith et al., 1982; Smith and Furcht, 1982) .
Preparation of proteolytic fragments of FN FN fragments were purified according to the general scheme of Smith et al. (1982) and Smith and Furcht (1982) with some modifications in the sequence of proteolytic digestion and affinity chromatography. Figure  1 summarizes the protocol used in this study and described below. Tables I and II were made using an average molecular weight for these fragments. (1982) and Smith and Furcht (1982) . This scheme of enzyme digestion and purification peritted mapping of the resulting the A chain of plasma FN (Hayashi and Yamada, 1983) . The location of this fragment on the molecule was established using monoclonal antibody and affinity chromatography. The two high molecular weight (Mr = 190,000 and 200,000) tryptic fragments of FN were purified by binding first to gelatin and then to heparin. Cathepsinization of these fragments for 15 min was performed to generate the remaining peptides. The location of these catheptic peptides along the intact FN molecule was also established with monoclonal antibody and affinity chromatography.
The 46,000-dalton fragment, containing domain II, binds to gelatin and is immediately adjacent to the 27,000-dalton tryptic fragment (domain I). The series of fragments ranging in M, from 80,000 to 125,000 contain domains III and IV. Domain IV represents a region of the molecule with M, = 11,500, which has been shown by Pierschbacher et al. (1981) to mediate fibroblast attachment to FN. The localization of domain IV was verified in the two high molecular weight bands in this preparation by reactivity with monoclonal antibody 3E3. Finally, two major (33,000-and 66,000-dalton) peptides and one minor (43,000-dalton) peptide that all bind heparin strongly were isolated from the catheptic digest. The 33,000-and 66,000-dalton heparin-binding fragments originate from the A and B chains of the FN molecule, respectively (Hayashi and Yamada, 1983; J. B. McCarthy, S. Hagen, and L. T. Furcht, unpublished observations). The 33,000-dalton fragment contains domain V, while the 66,000-dalton fragment contains both domains V and VI. This assertion is based on the reactivity of monoclonal antibody 2-8 with the 66,000-and not the 33,000-dalton heparin-binding fragment. The minor 43,000-dalton fragment presumably represents a breakdown product of the 66,000-dalton fragment, since it also binds monoclonal antibody 2-8. Trypsin apparently releases domain VI from the A chain but not the B chain (Hayashi and Yamada, 1983) , possibly as a result of the insertion of an A chain-specific amino acid sequence between domains V and VI (Schwarzbauer et al., 1983) . Importantly, domain IV, which has been shown to mediate cell attachment and binds monoclonal antibody 3E3, is absent from this series of heparin-binding fragments. Protein-binding assay. As previously described, intact FN binds to tissue culture plastic in a concentration-dependent manner (Palm and Furcht, 1983) . Radioactively labeled FN fragments also bound to plastic (Table II) . The amount of each fragment preparation that bound (Table II , column 1) greatly exceeds its contribution to the amount of intact FN bound. This is demonstrated by calculating the molar equivalent to intact FN of each bound fragment (Table II, 
column 3).
Neurite extension: Summary of response. In a previous study (Rogers et al., 1983) , we reported that PNS but not CNS neurons, cultured in serum-supplemented medium, extended neurites in response to substratum-bound FN. This was further examined in the present study with serum-free conditions. PNS neurons consistently formed neurites on FN when cultured without serum (Fig. 4A , Table III ). Occasionally, neurites formed in serum-free CNS cultures during the first 24 hr on intact FN, but only at the highest concentration of FN tested (200 pg/ml). The CNS cells tended to be more clumped than DRG cells grown on FN, raising the possibility that the observed neurites were initiated by interactions among CNS cells rather than supported by the FN substratrum alone. Neurites were not observed in CNS cultures on intact FN at 48 hr (Fig.  4E , Table III ).
The responses of PNS and CNS neurons to the preparations of FN and affinity-purified FN fragments are summarized in Table III . None of the cells studied extended neurites on the amino-terminal heparin-binding fragment (Fig. 2, lane a) , the Fig. 2 , lanes a to e, and the text for concentrations used).
46,000-dalton gelatin-binding fragment (Fig. 2, lane b) , or the COOH-terminal31,000-dalton free sulfhydryl-containing fragment (Fig. 2, lane e) of FN. DRG neurons extended and maintained neurites on the central non-heparin/non-gelatinbinding fragments (Fig. 2, lane c) containing regions reported by other investigators to mediate attachment of various cell types (Yamada, 1983) . All concentrations of this preparation used here (6 to 60 pg/ml) were effective in eliciting the DRG response, and neurites were present in these cultures through 48 hr (Fig. 4, B and C) . The 33,000/66,000-dalton COOHterminal heparin-binding preparation also supported DRG neurite outgrowth.
The highest concentration (60 pg/ml) of this preparation was consistently effective (Fig. 40) , and one-half this concentration was effective in most experiments, but the lowest concentration (6 pg/ml) never supported neurite extension. The responses of dissociated sympathetic ganglion cells to the above preparations were similar to those of DRG cells. Spinal cord neurons exhibited a complex response to the 80,000-to 125,000-dalton "cell-binding" preparation. During the first 24 hr of culture, neurites extended from many SC cells that were attached either individually or in clumps to the substratum (Fig. 4F ). This response was noted only when at least 60 gg/ml of this preparation was used. By 48 hr, the SC neurites had retracted, and cells were predominantly clumped and often completely detached from the substratum (Fig. 4G ). This was true even when the concentration of the fragments was increased to 120 @g/ml. The time course of these events was similar in several separate experiments.
In contrast, SC neurites were extended and maintained for at least 48 hr on the 33,000/66,000-dalton heparin-binding fragments (Fig. 4H) . Only the highest concentration of this preparation was consistently effective in supporting SC neurite outgrowth. Retinal cells exhibited responses similar to those of the SC cells to the 80,000-to 125,000-and the 33,000/66,000-dalton preparations. Cell-substratum adhesion. Optimal times for the cell adhesion assays were selected, after several trials with each cell type, on the basis of cells remaining attached in the uncoated wells (positive control) but predominantly unattached in the bovine serum albumin (BSA)-treated wells (negative control) following rinsing. We do not yet know which cell types in the heterogeneous DRG or SC cell populations adhered in these assays, but the pattern of cell adhesion to the fragments (see below) does correlate with ability to support neurite outgrowth.
This suggests that neurons do adhere during early phases of culture. Also, since non-neuronal cells are evident in longer-term cultures, it may be that all cells within these populations have relatively similar adhesive properties with respect to FN.
Compared to BSA-treated plastic, intact FN, the 80,000-to 125,000-dalton series of "cell-binding" fragments, and the 33,000/66,000-dalton heparin-binding fragments supported adhesion of relatively large numbers of DRG cells (Fig. 5A) . Each protein concentration that promoted DRG cell adhesion also supported neurite extension (see Fig. 4 and summary, above). In most cases, attachment at each of these concentrations exceeded attachment to untreated plastic. In contrast to the active preparations, few DRG cells attached to the 27,000-dalton heparin-binding, 46,000-dalton gelatin-binding, or 31,000-dalton sulfhydryl-containing fragments.
The diminished attachment to these fragments is not simply due to a small amount of protein bound to the plastic substrata (see Table II and "Protein-binding assay," above).
Like DRG cells, SC cells attached initially to the 80,000-to 125,000-dalton fragments (all concentrations) and to the 33,000/66,000-dalton region (two highest concentrations) in substantially greater numbers than to the 27,000-, 40,000-, and 31,000-dalton fragments (Fig. 5B) . Attachment to the latter three preparations did not exceed attachment to the BSA control. In contrast to the DRG response, there was little adhesion of SC cells to intact FN. Adhesion of SC cells to intact FN and FN fragments was consistently lower than that of DRG cells and required a longer period of time. That this lower rate of adhesion was specific to the SC cell-FN response, rather than a general property of these cells, is indicated by the rapid and substantial adhesion of SC cells to untreated plastic.
Neurite initiation. The extent to which DRG and SC cells initiated neurites on different substrata was examined by counting the number of total cells, rather than the number of neurons, with neurites. This was necessary for comparison of DRG and SC cells: whereas DRG neurons are relatively easy to distinguish from non-neuronal cells, SC neurons without neurites are not.
The percentage of DRG cells with neurites was relatively consistent on FN, the 80,000-to 125,000-dalton non-heparin/ non-gelatin-binding fragments, and the 33,000/66,000-dalton heparin-binding fragment (Table IV) . Since approximately one-half of the cells in the DRG preparation are neurons, about 2 times the percentages in Table IV , column 1 would represent the number of neurons with neurites. Approximately one-fourth to one-half of cells with neurites were in contact with other cell bodies (Table IV , column 2), raising the possibility that, in these instances, neurite initiation was supported by an adjacent cell surface rather than by the prepared substratum. However, in all other cases neurite initiation appeared to result from direct neuron-FN or neuron-FN fragment interaction.
A somewhat lower incidence of cell-cell interaction on the 33,000/ 66,000-dalton fragment (Table IV , column 2) was observed compared to that on the other fragments, but the biological significance of this is not yet clear. 
Substantial
numbers of SC cells initiated and maintained neurites on the highest concentration (60 pg/ml) of the 33,000/ 66,000-dalton heparin-binding fragments (Table V, column 1) . A large portion of these cells were attached directly to the substratum-bound protein rather than to adjacent cells (Table  V, column 2) . At a lower concentration (30 pg/ml) of these peptides, fewer cells formed neurites, and those that did were more often associated with other cells from the dissociated Vol. 5, No. 2, Feb. 1985 spinal cords than at the higher concentration (Table V, column 2).
Neurite length. In order to compare the relative effectiveness of intact FN, the centrally located "cell-binding" fragments, and the 33,000/66,000-dalton heparin-binding fragments in support of neurite outgrowth, DRG neurites on each preparation were measured. The neurite lengths provided an igdication of the rate of growth promoted by each experimental substratum. As Table VI illustrates, each preparation supported an approximately equivalent rate of neurite extension, although values varied somewhat between experiments. In other words, once initiated, DRG neurites grow equally well on each substratum. The very high standard deviations for average neurite length are due to the asynchronous nature of neurite initiation within each culture.
Discussion
The FN fragments used in this study have been extensively characterized in previous reports (Smith et al., 1982; Smith and Furcht, 1982) and again for analysis of neuronal interaction with the FN molecule. The predominant peptides in each of the five preparations studied here are unique in terms of molecular weight and ligand-binding properties. A 27,000-dalton peptide generated from the amino terminus binds heparin weakly; an adjacent 46,000-dalton fragment binds gelatin but not heparin, and a 31,000-dalton carboxyl terminus peptide contains a free sulfhydryl but does not bind either ligand. These three peptides do not support adhesion of neurons or other cell types (Furcht, 1983) . The two remaining peptide preparations are also distinct. (I) The 33,000-and 66,000-dalton fragments both bind heparin strongly, whereas the 80,000-to 125,000-dalton fragments do not. (2) The 80,000-to 125,000-but not the 33,000/66,000-dalton fragments contain the antigenic determinant recognized by monoclonal antibody 3E3, which has been reported to inhibit cell attachement to intact FN (Pierschbather et al., 1981) . (3) There are no co-migrating peptides when visualized by SDS-PAGE.
In addition to the different ligand-and monoclonal antibody-binding properties of the 33,000/66,000-and 80,000 to 125,000-dalton fragment populations, the cell behavior reported here strongly suggests that each of these two fragments contain regions that can mediate or modulate cell attachment and neurite extension, possibly by different mechanisms.
CNS and PNS neurons differ in their responses to the FN molecule. In summary, peripheral neurons bind to and extend neurites on (I) intact FN, (2) tryptic/catheptic fragments (80,000 to 125,000 daltons) that contain previously described cell-binding activity (Furcht, 1983) , and (3) 33,000-and 66,000. dalton COOH-terminus fragments with strong heparin-binding activity. CNS cells bind to both the 80,000-to 125,000. and the 33,000/66,000-dalton fragments but maintain neurite growth only on the 33,000-and 66,000-dalton fragments. Both adhesion and neurite formation by CNS cells in response to intact FN was minimal. These responses raise three related questions concerning neuron-FN interactions: (I) Why do CNS cells interact with two proteolytic FN fragments, but not with intact FN? (2) What is the nature of the difference between central and peripheral neurons? and (3) What is the significance of each active region with respect to neuronal interaction with the intact FN molecule?
Initial adhesion of CNS cells to the 33,000/66,000-and 80,000-to 125,000-dalton fragments, in comparison with FN, suggests exposure of binding sites on these peptides that are not available in intact FN when it is bound to plastic. FN has been shown to change shape (Tooney et al., 1983) and binding properties (Grinnell and Feld, 1981) et al., 1981) . It must be emphasized that we also do not know the precise conformation of FN in uiuo. Although it appears to be globular at neutral pH (Tooney et al., 1983) , the shape of FN in extracellular matrices is not clear: the complexity and flexibility of the molecule suggest that its configuration may vary with its roles in cell-cell interaction, or in cell binding to collagen or other extracellular materials. Therefore, it is possible that CNS as well as PNS neurons do interact with FN during certain events in uiuo.
In addition to the marked difference in response of CNS versus PNS cells to intact FN, adhesive interactions with the 80,000-to 125,000-dalton fragments also differ. Although CNS cells attached to, and many extended neurites on, these centrally derived peptides, neurite withdrawal beginning at approximately 24 hr was rapid and complete, possibly due to loss of neurite adhesivity (Letourneau, 1975) . Decreased cell-substratum adhesivity was also indicated by a marked clumping of cells when neurite retraction occurred. Cells commonly clump when seeded onto a poorly adhesive substratum. One explanation for this alteration in adhesivity is that the neurite growth cones, and possibly other CNS cells, may degrade the FN fragments, eventually depleting the protein so that cell-substratum adhesion is greatly diminished. An important alternative is that these cells initially have the necessary binding sites for attachment to this domain of FN, but as the surface area is expanded through neurite growth, binding sites are not maintained in sufficient quantity, proper orientation, or required combination with other molecules to sustain neurite adhesivity. The isolation of two different fragments of FN which promote neurite outgrowth, and the differential response of CNS neurons to the fragments, suggest the existence of multiple interactions of the cell surface with intact FN. Three types of interaction can be hypothesized. First, adhesive interaction of the neuronal cell surface with particular conformations of both the centrally located "cell-binding" and the COOH-terminal heparin-binding domains might be required for successful neurite adhesion to intact FN. Second, cells might bind initially to one region of intact FN, with subsequent interaction with the other region modulating or stabilizing their behavior. The latter interaction might lead to detachment of CNS cells from the molecule. Both of these models imply that there are two separate and distinct sites on FN that interact with cells. A third model involves a cell-binding site common to both the 33,000/ 66,000-and the 80,000-to 125,000-dalton fragments, with additional activity present in the conformation of the latter peptides that promotes detachment of CNS cells. Although our data on ligand-binding and neuronal activity do not support the existence of such a common region, until we know the precise amino acid sequences of the active regions of these FN fragments we cannot rule out this possibility.
It still might be argued that the "cell-binding" regions of each fragment are essentially identical and that the active sequences of the 80,000-125,000-dalton fragments (domain IV) are also present in the 33,000/66,000-dalton preparation but in smaller amounts (i.e., contamination).
This might then account for the fact that higher concentrations of the 33,000/66,000-dalton peptides (molar equivalents to 100 to 200 Kg/ml of intact FN) compared to the 80,000-to 125,000-dalton peptides (molar equivalents to 1 to 100 fig/ml of intact FN) were needed to elicit the observed PNS cell behavior. However, this explanation is unlikely because (I) CNS cells would not be expected to exhibit a greater, more stable response to the "contaminant" in the 33,000/66,000-dalton preparation than to the active portions of the 80,000-to 125,000-dalton fragments, and (2) CNS cells should respond to high levels of the 80,000-to 125,000-dalton fragments at least as well as to equivalent levels of the 33,000/66,000-dalton peptide, but, in fact, they do not. Although our observations probably do not, therefore, reflect a dose response, it is still possible that sites within each preparation are similar, with additional activity in the 33,000/66,000-dalton peptide that stabilizes the CNS cells. If this were the case, a fundamental difference between the two fragment populations, in terms of interaction with cells, would still exist.
Multiple interactions of cells with FN suggest multiple types of cell surface-binding sites that might be used during different types or phases of cell attachment and movement. It seems likely that a heparan sulfate proteoglycan is involved in cell interaction with the heparin-binding domain of the FN molecule. Cell attachment and neurite extension on proteoglycanbinding proteins has shown that cell surface proteoglycans can be utilized for these activities (Chernoff and Culp, 1983; Laterra et al., 1983a, b) . Importantly, heparan sulfate proteoglycan has been reported to be a transmembrane component capable of interacting with the cytoskeleton (Rapraeger and Bernfield, 1982) and thereby influencing cell behavior.
Since intact FN binds heparin, another approach to examining the importance of this activity to cell-FN interaction has been to competitively inhibit this interaction with exogenous heparin. Carbonetto et al. (1983) report that added heparin does inhibit neurite extension on FN, implying involvement of cell surface heparan sulfate, but our attempts to utilize this approach have been inconclusive (unpublished observations). In both cases, the effects of heparin may be at least partially independent of the presence of FN, as heparin-treated surfaces are highly anionic and thus unattractive for cells. Furthermore, if the heparin-binding region of FN is cryptic when certain binding conditions are used, as our data and others ' (Gold et al., 1983; Sekiguchi et al., 1983) suggest, heparin inhibition of cellular activity would be nonspecific. It will be important to test the involvement of cell surface heparan sulfate (which is complexed with protein) using a heparan sulfate proteoglycan or an antibody to the molecule, rather than heparin, to interfere with cell-FN and cell-FN fragment interaction.
Indeed, one report shows that cell interaction with FN is specifically inhibited by heparan sulfate proteoglycan but not by heparin (Klebe and Mock, 1982) .
It should be noted that there is evidence to suggest that heparan sulfate may also directly mediate cell attachment and neurite extension via a FN-independent mechanism(s). For example, the substratum-bound factor from conditioned medium described by Lander et al. (1982) appears to contain a proteoglycan that promotes neurite extension. It is conceivable that, in our culture system, the substratum-bound heparinbinding FN fragments bind extracellular heparan sulfate, which in turn binds neuronal cell surfaces. Such binding could involve specific cell surface polysaccharide receptors and/or intercalation of proteoglycan core proteins into the plasma membrane (Kjellan et al., 1980) , thus facilitating cell association with extracellular matrix glycosaminoglycans or proteoglycans. Clearly, precise localization of these molecules and their relationship to cell surface-mediated behavior will require further investigation.
Interaction of neurons and other cell types with a nonheparin/non-gelatin-binding (i.e., "cell binding") region of FN (Ruoslahti et al., 1981; Albini et al., 1983; Carbonetto et al., 1983; Yamada, 1983 ; J. B. McCarthy, S. Hagen, and L. T.
Furcht, unpublished observations) implicates cell surface molecules in addition to heparan sulfate proteoglycan that will mediate cell attachment. The manner in which cells utilize the two regions of the FN molecule may vary significantly with cell type and activity as well as with FN conformation. For example, spreading and formation of specialized adhesive contacts by non-neuronal cells appear to require interaction with both cellbinding and heparin-binding domains (Izzard and Culp, 1983; Laterra et al., 1983a, b) . On the other hand, our results indicate that neurons can use the heparin-binding domain alone for adhesion and extension of neurites, although interaction with intact FN may involve multiple cell surface constituents. Such different responses to FN might reflect differences between cell types in modes of locomotion. Whereas formation of highly adherent focal contacts on heparin-binding proteins (Laterra et al., 1983a, b) may actually impede locomotion of cells that must also break these contacts in order to move, neuronal growth cones move very well over extremely adhesive surfaces (Letourneau, 1975) . The heparin-binding region of FN apparently provides such a surface, but initial cell adhesion to the cell-binding region is even greater when the two are compared on a molar basis. It is still unclear how each region interacts with cell surfaces to promote cell-specific behavior, and it will be helpful when the membrane molecules involved, as well as their interaction with cytoskeletal components, are more fully understood. It is plausible that domain-specific and cell-specific multivalent interactions will account for variations in cell behavior mediated by FN.
In summary, the responses of PNS and CNS neurons to isolated regions of FN may involve different adhesive molecules on the surfaces of these cells. While one heparin-binding region of FN binds to and promotes neurite outgrowth from both types of neurons, a second region supports sustained neurite growth only from PNS neurons. Stable interaction of CNS neurons with a heparin-binding domain but not with the previously reported "cell-binding" region or with the intact FN molecule suggests (1) absence, or insufficient numbers, on CNS cells of an "FN receptor" unrelated to heparin-binding,
insufficient or improper accessibility of the heparin-binding region in the nonfragmented molecule, and/or (3) multiple cell surface interactions with intact FN that modulate adhesive contacts. We do not yet know how the two regions described here, either individually or in combinat,ion with one another, are involved in neuronal interaction with intact FN. Such information will require further studies involving antibodies against each active site, isolation of smaller peptides from these regions, and inhibition of cell behavior with molecules that compete with cell surface-binding sites. Finally, understanding of the various roles of FN in development and regeneration may require consideration of multiple mechanisms by which this molecule mediates cellular adhesion and locomotion.
